The adaptation of emerging data and therapies into clinical practice is vital to improving patient outcomes. We support oncologists by connecting them with distinguished leaders, and mobilizing data around the globe. https://bit.ly/3sW5GT3
Cancer Expert Now’s Post
More Relevant Posts
-
Stay up to date with the latest in Alzheimer’s treatment with #IQVIA’s latest white paper on the subject. Learn about the potential of upcoming anti-β-amyloid (Aβ) therapeutic strategies and how they may reshape the market. #Oncology https://bit.ly/3R1cbOk
Aβ-Directed Therapies in Alzheimer's Disease
iqvia.com
-
Don't miss the EMA/EORTC workshop 👉 How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions? 📅 29 February https://europa.eu/!TVfryM How can you take part? ✍ In-person registration open until 15 January 💻 Online registration open until 16 February The event will explore the importance of patient-reported data in shaping regulatory decisions on cancer treatments, featuring expert speakers and an interactive discussion with industry, academia, regulatory agencies, health technology assessment bodies, healthcare professionals and patients. #cancerawareness #treatcancer #research
-
-
🎥 Excited to share how MatchTrial empowers cancer patients and healthcare HCP through clinical trials. Since our launch in 2021, we've become a beacon of hope for over 10,000 users across Spain and France. We're dedicated to connecting patients with the most suitable clinical trials, providing ongoing support, and building a network of empowerment. Our journey is filled with stories of courage, resilience, and the power of connection! Join us in celebrating these milestones and our positive impact on patients' lives. Together, we can continue to deliver the best care possible. Looking for strategies to maximize patient participation in clinical trials? 💭 Dive into our latest blog post: "Maximizing Participation: Proven Patient Recruitment Strategies in Clinical Trials" https://lnkd.in/gaaqcnad #ClinicalTrials #PatientEmpowerment #HealthcareInnovation #PatientRecruitment #MatchTrial
-
Did you know Inspire has helped researchers advance progress for more than 100 diseases? Inspire works with life sciences companies to provide real-world evidence and insights about the patient experience, connect patients with life-advancing clinical trials, and enable medical breakthroughs. What can Inspire help you discover? https://ow.ly/hGvc50Q7zW1 #RWE #RealWorldEvidence #PatientVoice #PatientExperience #PatientCentricity
Real World Evidence - Inspire
https://corp.inspire.com
-
I can't wait to join this discussion next week about how we can improve the prospective collection of #realworlddata in routine care settings!#realworldevidence #clinicaltrials #clinicalresearch
Transforming healthcare systems by using data and AI to drive value, equity, and innovation
Improving point-of-entry data collection is a crucial step toward achieving a true learning healthcare system in the US. Better data empowers population health initiatives, fuels value-based care models, drives cutting-edge research, enhances care quality, and ultimately, fosters healthy longevity. As the utilization of AI continues to expand, the significance of data quality becomes even more pronounced, as the outputs of AI models are only as reliable as the inputs they receive. In oncology, RWD has already made remarkable strides in advancing the development of life-saving medical products. However, the intricacies of cancer care and the challenges in capturing relevant data have hindered the realization of its full potential. Join Mark Stewart and me as we delve into these critical issues in oncology RWD. Our esteemed panel of leaders includes Paul Kluetz (FDA), Phil Lindemann (Epic), Molly O'Grady Prieto, MPA (Office of the National Coordinator for Health Information Technology (ONC), Brian Anderson, MD (MITRE), @ Stephen (Fred) Divers (American Oncology Network), and Neal Meropol (Flatiron Health) 🚀See you on Jan 20🚀 https://lnkd.in/eV6Rp8hq
Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology
advancingrwdinoncologyworkshop.splashthat.com
-
An important discussion to add to your February calendar 🗓️ #cancer #stakeholder #engagement
Don't miss the EMA/EORTC workshop 👉 How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions? 📅 29 February https://europa.eu/!TVfryM How can you take part? ✍ In-person registration open until 15 January 💻 Online registration open until 16 February The event will explore the importance of patient-reported data in shaping regulatory decisions on cancer treatments, featuring expert speakers and an interactive discussion with industry, academia, regulatory agencies, health technology assessment bodies, healthcare professionals and patients. #cancerawareness #treatcancer #research
-
-
Check out what our Co-Founder, Jonny Imerman and other brilliant cancer survivors have to say about humanizing healthcare!
"You can make great research and great medicine, but if you’re not supporting the whole patient — you’re not supporting us at all.” Loriana Hernandez-Aldama Read more from Loriana and the rest of our #DPEast23 panel in MM+M: https://bit.ly/3Rvx4RZ Yesenia Bautista Loriana Hernandez-Aldama Imerman Angels CLŌZTALK
DPE 2023 panel recap: Cancer survivors call on healthcare marketers to ‘humanize healthcare'
https://www.mmm-online.com
-
Don't miss the EMA/EORTC workshop 👉 How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions? 📅 29 February https://europa.eu/!TVfryM The event will explore the importance of patient-reported data in shaping regulatory decisions on cancer treatments, featuring expert speakers and an interactive discussion with industry, academia, regulatory agencies, health technology assessment bodies, healthcare professionals and patients. #cancerawareness #treatcancer #research
-
-
Global Client Partner, Chair, US Board of Partners and Principals PwC IL Board Member and US & Mexico Sales Leader
Two recent publications highlight how SPARK stands to accelerate progress on new treatments and improve patient outcomes
Breaking Down Barriers to Pancreatic Cancer Research: Two New Publications Highlight PanCAN’s Work
pancan.org
-
Elevate your market insights with PIVOT reports and bridge the gap between clinical practice and market strategy. Engage digitally with community oncologists, understand clinical practice trends, and align your strategy with the latest in #CancerCare. https://lnkd.in/dXAvsFBF
Click to Read More!
https://www.aptitudehealth.com
